Related Experiment Video
Updated: Jun 30, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
The role of RNA-modifying proteins in renal cell carcinoma
Muna A Alhammadi1,2, Khuloud Bajbouj3,4,5, Iman M Talaat6,7,8
1Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, P.O. Box 27272, United Arab Emirates. u21107591@sharjah.ac.ae.
Abstract:
Gene expression is one of the most critical cellular processes. It is controlled by complex mechanisms at the genomic, epigenomic, transcriptomic, and proteomic levels. Any aberration in these mechanisms can lead to dysregulated gene expression. One recently discovered process that controls gene expression includes chemical modifications of RNA molecules by RNA-modifying proteins, a field known as epitranscriptomics. Epitranscriptomics can regulate mRNA splicing, nuclear export, stabilization, translation, or induce degradation of target RNA molecules. Dysregulation in RNA-modifying proteins has been found to contribute to many pathological conditions, such as cancer, diabetes, obesity, cardiovascular diseases, and neurological diseases, among others. This article reviews the role of epitranscriptomics in the pathogenesis and progression of renal cell carcinoma. It summarizes the molecular function of RNA-modifying proteins in the pathogenesis of renal cell carcinoma.
Insights
Epitranscriptomics, the study of RNA modifications, plays a crucial role in regulating gene expression. Aberrations in RNA-modifying proteins are linked to renal cell carcinoma development and progression.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Gene expression is vital for cellular function, regulated by complex genomic, epigenomic, transcriptomic, and proteomic mechanisms.
- Epitranscriptomics, involving chemical modifications of RNA by RNA-modifying proteins, is a newly discovered layer of gene expression control.
- Dysregulation of RNA-modifying proteins is implicated in various diseases, including cancer.
Purpose of the Study:
- To review the role of epitranscriptomics in the pathogenesis and progression of renal cell carcinoma (RCC).
- To summarize the molecular functions of RNA-modifying proteins in RCC development.
Main Methods:
- Literature review of epitranscriptomics and renal cell carcinoma.
- Analysis of molecular functions of RNA-modifying proteins in RCC pathogenesis.
Main Results:
- Epitranscriptomics influences mRNA splicing, nuclear export, stabilization, translation, and degradation.
- RNA-modifying protein dysregulation is a significant factor in RCC pathogenesis.
- Specific molecular functions of these proteins contribute to RCC progression.
Conclusions:
- Epitranscriptomics represents a critical regulatory layer in gene expression with implications for RCC.
- Understanding RNA-modifying proteins offers insights into RCC pathogenesis and potential therapeutic targets.
More Related Videos
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
11:11Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
Related Concept Videos
RNA Editing
RNA Stability
Experimental RNAi
Regulation of Expression at Multiple Steps
Types of RNA
RNA Performs Diverse...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...